These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 33340663

  • 1. Discovery of a series of 1H-pyrrolo[2,3-b]pyridine compounds as potent TNIK inhibitors.
    Yang B, Wu Q, Huan X, Wang Y, Sun Y, Yang Y, Liu T, Wang X, Chen L, Xiong B, Zhao D, Miao Z, Chen D.
    Bioorg Med Chem Lett; 2021 Feb 01; 33():127749. PubMed ID: 33340663
    [Abstract] [Full Text] [Related]

  • 2. Discovery of 3,5-disubstituted-1H-pyrrolo[2,3-b]pyridines as potent inhibitors of the insulin-like growth factor-1 receptor (IGF-1R) tyrosine kinase.
    Patnaik S, Stevens KL, Gerding R, Deanda F, Shotwell JB, Tang J, Hamajima T, Nakamura H, Leesnitzer MA, Hassell AM, Shewchuck LM, Kumar R, Lei H, Chamberlain SD.
    Bioorg Med Chem Lett; 2009 Jun 01; 19(11):3136-40. PubMed ID: 19394223
    [Abstract] [Full Text] [Related]

  • 3. Design, synthesis and biological evaluation of 1H-pyrrolo[2,3-b]pyridine and 1H-pyrazolo[3,4-b]pyridine derivatives as c-Met inhibitors.
    Liu N, Wang Y, Huang G, Ji C, Fan W, Li H, Cheng Y, Tian H.
    Bioorg Chem; 2016 Apr 01; 65():146-58. PubMed ID: 26950400
    [Abstract] [Full Text] [Related]

  • 4. Design and synthesis of novel pyrrolo[2,3-b]pyridine derivatives targeting V600EBRAF.
    Abdel-Maksoud MS, Ali EMH, Ammar UM, Mersal KI, Yoo KH, Oh CH.
    Bioorg Med Chem; 2020 Jun 01; 28(11):115493. PubMed ID: 32340792
    [Abstract] [Full Text] [Related]

  • 5. Discovery of 7H-pyrrolo[2,3-d]pyridine derivatives as potent FAK inhibitors: Design, synthesis, biological evaluation and molecular docking study.
    Wang R, Zhao X, Yu S, Chen Y, Cui H, Wu T, Hao C, Zhao D, Cheng M.
    Bioorg Chem; 2020 Sep 01; 102():104092. PubMed ID: 32707280
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Design, synthesis, and docking studies of phenylpicolinamide derivatives bearing 1H-pyrrolo[2,3-b]pyridine moiety as c-Met inhibitors.
    Zhu W, Wang W, Xu S, Tang Q, Luo R, Wang M, Gong P, Zheng P.
    Bioorg Med Chem; 2016 Feb 15; 24(4):812-9. PubMed ID: 26810712
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. 1H-pyrrolo[2,3-b]pyridine: A new scaffold for human neutrophil elastase (HNE) inhibitors.
    Crocetti L, Giovannoni MP, Schepetkin IA, Quinn MT, Khlebnikov AI, Cantini N, Guerrini G, Iacovone A, Teodori E, Vergelli C.
    Bioorg Med Chem; 2018 Nov 15; 26(21):5583-5595. PubMed ID: 30385225
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Discovery of novel pyrrolo[2,3-b]pyridine derivatives bearing 1,2,3-triazole moiety as c-Met kinase inhibitors.
    Tang Q, Wang L, Tu Y, Zhu W, Luo R, Tu Q, Wang P, Wu C, Gong P, Zheng P.
    Bioorg Med Chem Lett; 2016 Apr 01; 26(7):1680-4. PubMed ID: 26923692
    [Abstract] [Full Text] [Related]

  • 19. Potent Pyrimidine and Pyrrolopyrimidine Inhibitors of Testis-Specific Serine/Threonine Kinase 2 (TSSK2).
    Hawkinson JE, Sinville R, Mudaliar D, Shetty J, Ward T, Herr JC, Georg GI.
    ChemMedChem; 2017 Nov 22; 12(22):1857-1865. PubMed ID: 28952188
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.